The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
MicroRNA-140-5p suppresses tumor growth and metastasis by targeting transforming growth factor β receptor 1 and fibroblast growth factor 9 in hepatocellular carcinoma
Open accessAbstract
By comparing the expression profiles of microRNAs (miRNAs) in different hepatocellular carcinoma (HCC) subtypes, we identified miR-140-5p as an HCC-related miRNA. We found that miR-140-5p was significantly decreased in HCC tissues and all of six liver cancer cell lines examined and its expression levels were correlated with multiple nodules, vein invasion, capsular formation, and differentiation, as well as overall and disease-free survival of HCC. We also found that miR-140-5p suppressed HCC cell proliferation and HCC metastasis. Multipathway reporter arrays suggested that miR-140-5p inhibited transforming growth factor β (TGF-β) and mitogen-activated protein kinase / extracellular signal-regulated kinase (MAPK/ERK) signaling. TGFB receptor 1 (TGFBR1) and fibroblast growth factor 9 (FGF9) were then characterized as the direct targets for miR-140-5p after it was found that ectopic miR-140-5p expression suppressed TGFBR1 and FGF9 expression. Silencing TGFBR1 and FGF9 by small interfering RNA (siRNA) resembled the phenotype resulting from ectopic miR-140-5p expression, while overexpression of TGFBR1 and FGF9 attenuated the effect of miR-140-5p on HCC growth and metastasis. Conclusion: These data elucidated a tumor suppressor role for miR-140-5p in HCC development and progression with therapeutic potential. Our correlation studies in clinical HCC samples further suggest that miR-140-5p could be a valuable biomarker for HCC prognosis. (Hepatology 2013 )
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Bartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714
Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers
Calin, G. A., Sevignani, C., Dumitru, C. D., Hyslop, T., Noch, E., Yendamuri, S., Shimizu, M., Rattan, S., Bullrich, F., Negrini, M., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307323101 · Cited by 4,095
Llovet, J. M., Burroughs, A., & Bruix, J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14964-1 · Cited by 3,608
Fibroblast growth factor signalling: from development to cancer
Turner, N., & Grose, R. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2780 · Cited by 2,693
Primary liver cancer: Worldwide incidence and trends
Bosch, F. X., Ribes, J., Díaz, M., & Cléries, R. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.011 · Cited by 2,477
TGF-β signaling: positive and negative effects on tumorigenesis
Wakefield, L. (2002) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(01)00259-3 · Cited by 827
Mechanisms of miRNA-mediated post-transcriptional regulation in animal cells
Chekulaeva, M., & Filipowicz, W. (2009) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2009.04.009 · Cited by 685
Szabo, G., & Bala, S. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.87 · Cited by 588
Sethupathy, P., Megraw, M., & Hatzigeorgiou, A. G. (2006) · Nature Methods · doi:10.1038/nmeth954 · Cited by 541
Xu, T., Zhu, Y., Xiong, Y., Ge, Y.-Y., Yun, J.-P., & Zhuang, S.-M. (2009) · Hepatology · doi:10.1002/hep.22919 · Cited by 372
Fang, J.-H., Zhou, H.-C., Zeng, C., Yang, J., Liu, Y., Huang, X., Zhang, J.-P., Guan, X.-Y., & Zhuang, S.-M. (2011) · Hepatology · doi:10.1002/hep.24577 · Cited by 307
Wang, X. W., Heegaard, N. H. H., & Ørum, H. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.04.007 · Cited by 280
Hendrix, N. D., Wu, R., Kuick, R., Schwartz, D. R., Fearon, E. R., & Cho, K. R. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3694 · Cited by 276
Liang, L., Wong, C.-M., Ying, Q., Fan, D. N.-Y., Huang, S., Ding, J., Yao, J., Yan, M., Li, J., Yao, M., et al. (2010) · Hepatology · doi:10.1002/hep.23904 · Cited by 241
Molecular Pathways: Targeting the TGF-β Pathway for Cancer Therapy
Smith, A. L., Robin, T. P., & Ford, H. L. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-3224 · Cited by 193
Yang, L.-Y., Fang, F., Ou, D.-P., Wu, W., Zeng, Z.-J., & Wu, F. (2009) · Annals of Surgery · doi:10.1097/sla.0b013e3181904988 · Cited by 192
Self-citationMicroRNAs in Pathogenesis, Diagnosis, and Treatment of Gastroesophageal Cancers
Song, J. H., & Meltzer, S. J. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.05.003 · Cited by 176
Biology of Hepatocellular Carcinoma
Pang, R. W. C., Joh, J. W., Johnson, P. J., Monden, M., Pawlik, T. M., & Poon, R. T. P. (2008) · Annals of Surgical Oncology · doi:10.1245/s10434-007-9730-z · Cited by 174
Yang, F., Yin, Y., Wang, F., Wang, Y., Zhang, L., Tang, Y., & Sun, S. (2010) · Hepatology · doi:10.1002/hep.23566 · Cited by 173
Quantitative miRNA expression analysis: comparing microarrays with next-generation sequencing
Willenbrock, H., Salomon, J., Søkilde, R., Barken, K. B., Hansen, T. N., Nielsen, F. C., Møller, S., & Litman, T. (2009) · RNA · doi:10.1261/rna.1699809 · Cited by 158
hsa-miR-191 Is a Candidate Oncogene Target for Hepatocellular Carcinoma Therapy
Elyakim, E., Sitbon, E., Faerman, A., Tabak, S., Montia, E., Belanis, L., Dov, A., Marcusson, E. G., Bennett, C. F., Chajut, A., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1313 · Cited by 155
Wu, F., Yang, L., Li, Y., Ou, D., Chen, D., & Fan, C. G. (2009) · Hepatology · doi:10.1002/hep.23197 · Cited by 140
Self-citationAnalyzing mRNA expression identifies Smad3 as a microRNA-140 target regulated only at protein level.
Pais, H., Nicolás, F. E., Soond, S., Swingler, T., Clark, I., Chantry, A., Moulton, V., & Dalmay, T. (2010) · RNA: A publication of the RNA Society · doi:10.1261/rna.1701210 · Cited by 134
Genomic analysis reveals RhoC as a potential marker in hepatocellular carcinoma with poor prognosis
Wang, W., Yang, L.-Y., Huang, G.-W., Lu, W.-Q., Yang, Z.-L., Yang, J.-Q., & Liu, H. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601749 · Cited by 119
Self-citationLi, L., Shi, J., Zhu, G., & Shi, B. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23457 · Cited by 110
Takata, A., Otsuka, M., Yoshikawa, T., Kishikawa, T., Hikiba, Y., Obi, S., Goto, T., Kang, Y. J., Maeda, S., Yoshida, H., et al. (2012) · Hepatology · doi:10.1002/hep.26011 · Cited by 94
Somatic Acquisition and Signaling of TGFBR1 *6A in Cancer
Pasche, B., Knobloch, T. J., Bian, Y., Liu, J., Phukan, S., Rosman, D., Kaklamani, V., Baddi, L., Siddiqui, F., Frankel, W., et al. (2005) · JAMA · doi:10.1001/jama.294.13.1634 · Cited by 92
Yang, F., Strand, D. W., & Rowley, D. R. (2007) · Oncogene · doi:10.1038/sj.onc.1210663 · Cited by 86
Molecular Pathways: MicroRNAs as Cancer Therapeutics
Melo, S. A., & Kalluri, R. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2010 · Cited by 73
Role of TGF-β in cancer and the potential for therapy and prevention
Kaklamani, V., & Pasche, B. (2004) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.4.4.649 · Cited by 58
Fěng, F., Luo, L., Tao, Y., Wu, F., & Yang, L. (2009) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0575 · Cited by 52
Self-citationWu, F., Liu, S., Tao, Y., Ou, D., Fang, F., & Yang, L. (2008) · Cancer · doi:10.1002/cncr.23396 · Cited by 40
Self-citationWang, X., Yang, L., Guo, L., Fan, C. G., & Wu, F. (2009) · Cancer · doi:10.1002/cncr.24494 · Cited by 35
Self-citationSomaticFGF9mutations in colorectal and endometrial carcinomas associated with membranousβ-catenin
Abdel‐Rahman, W. M., Kalinina, J., Shoman, S., Eissa, S., Ollikainen, M., Elomaa, O., Eliseenkova, A. V., Bützow, R. C., Mohammadi, M., & Peltomäki, P. (2007) · Human Mutation · doi:10.1002/humu.20653 · Cited by 32
Cited by
The Fibroblast Growth Factor signaling pathway
Ornitz, D. M., & Itoh, N. (2015) · WIREs Developmental Biology · doi:10.1002/wdev.176 · Cited by 2,050
Michelotti, G. A., Machado, M. V., & Diehl, A. M. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.183 · Cited by 974
TGF-β Signaling from Receptors to Smads
Hata, A., & Chen, Y.-G. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a022061 · Cited by 888
Signaling Receptors for TGF-β Family Members
Heldin, C.-H., & Moustakas, A. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a022053 · Cited by 711
Yu, T., Li, J., Yan, M., Liu, L., Lin, H., Zhao, F., Sun, L., Zhang, Y., Cui, Y., Zhang, F., et al. (2015) · Oncogene · doi:10.1038/onc.2013.574 · Cited by 264
Metadata
- Authors
- Yang, H., Fang, F., Chang, R., & Yang, L.
- Venue
- Hepatology
- Published
- 2013-07
- Volume
- 58
- Issue
- 1
- Pages
- 205-217
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2018234708
- Cited by
- 261
- References
- 35
- FWCI
- 9.83
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.